GlassScriptPhysician profile
Anupama Bhatt
NPI 1649562380
$2,042.34
in general payments reported to CMS, 2019-2025
11 companies · $560 in 2025
The $560 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $202 · 2023: $180 · 2024: $1,100 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,089 · Food and Beverage: $688 · Entertainment: $64.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,088.60 |
| Food and Beverage | $687.70 |
| Entertainment | $64.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,277.96 | 2022-2025 | Triclip, Cardiomems |
| Novo Nordisk INC | $160.40 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Boston Scientific Corporation | $149.76 | 2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $118.08 | 2022-2025 | Eliquis, Camzyos |
| Pfizer INC. | $111.52 | 2022-2025 | |
| Stereotaxis INC | $64.12 | 2025 | Genesis |
| Atricure, INC. | $52.50 | 2022 | |
| Edwards Lifesciences Corporation | $44.60 | 2023 | Pascal |
| Amgen INC. | $29.92 | 2023 | Repatha |
| Philips North America LLC | $18.76 | 2025 | Mcot |
| Sanofi-Aventis U.S. LLC | $14.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anupama Bhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.